• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单细胞转录组谱分析指导高效重编程人源体细胞为交叉呈递树突状细胞。

Single-cell transcriptional profiling informs efficient reprogramming of human somatic cells to cross-presenting dendritic cells.

机构信息

Molecular Medicine and Gene Therapy, Lund Stem Cell Centre, Lund University, BMC A12, 221 84 Lund, Sweden.

Wallenberg Centre for Molecular Medicine, Lund University, BMC A12, 221 84 Lund, Sweden.

出版信息

Sci Immunol. 2022 Mar 4;7(69):eabg5539. doi: 10.1126/sciimmunol.abg5539.

DOI:10.1126/sciimmunol.abg5539
PMID:35245086
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7613284/
Abstract

Type 1 conventional dendritic cells (cDC1s) are rare immune cells critical for the induction of antigen-specific cytotoxic CD8 T cells, although the genetic program driving human cDC1 specification remains largely unexplored. We previously identified PU.1, IRF8, and BATF3 transcription factors as sufficient to induce cDC1 fate in mouse fibroblasts, but reprogramming of human somatic cells was limited by low efficiency. Here, we investigated single-cell transcriptional dynamics during human cDC1 reprogramming. Human induced cDC1s (hiDC1s) generated from embryonic fibroblasts gradually acquired a global cDC1 transcriptional profile and expressed antigen presentation signatures, whereas other DC subsets were not induced at the single-cell level during the reprogramming process. We extracted gene modules associated with successful reprogramming and identified inflammatory signaling and the cDC1-inducing transcription factor network as key drivers of the process. Combining IFN-γ, IFN-β, and TNF-α with constitutive expression of cDC1-inducing transcription factors led to improvement of reprogramming efficiency by 190-fold. hiDC1s engulfed dead cells, secreted inflammatory cytokines, and performed antigen cross-presentation, key cDC1 functions. This approach allowed efficient hiDC1 generation from adult fibroblasts and mesenchymal stromal cells. Mechanistically, PU.1 showed dominant and independent chromatin targeting at early phases of reprogramming, recruiting IRF8 and BATF3 to shared binding sites. The cooperative binding at open enhancers and promoters led to silencing of fibroblast genes and activation of a cDC1 program. These findings provide mechanistic insights into human cDC1 specification and reprogramming and represent a platform for generating patient-tailored cDC1s, a long-sought DC subset for vaccination strategies in cancer immunotherapy.

摘要

1 型传统树突状细胞(cDC1)是诱导抗原特异性细胞毒性 CD8 T 细胞的罕见免疫细胞,尽管驱动人类 cDC1 特化的遗传程序在很大程度上仍未得到探索。我们之前已经确定了 PU.1、IRF8 和 BATF3 转录因子足以在小鼠成纤维细胞中诱导 cDC1 命运,但人类体细胞的重编程效率较低。在这里,我们研究了人类 cDC1 重编程过程中的单细胞转录动态。从胚胎成纤维细胞中产生的人诱导性 cDC1(hiDC1)逐渐获得了全局 cDC1 转录谱,并表达了抗原呈递特征,而在重编程过程中,其他 DC 亚群在单细胞水平上并未被诱导。我们提取了与成功重编程相关的基因模块,并确定了炎症信号和诱导 cDC1 的转录因子网络是该过程的关键驱动因素。将 IFN-γ、IFN-β 和 TNF-α与诱导 cDC1 的转录因子的组成型表达相结合,可将重编程效率提高 190 倍。hiDC1 吞噬死亡细胞,分泌炎症细胞因子,并进行抗原交叉呈递,这是 cDC1 的关键功能。这种方法允许从成体成纤维细胞和间充质基质细胞中高效生成 hiDC1。从机制上讲,PU.1 在重编程的早期阶段表现出主导和独立的染色质靶向,将 IRF8 和 BATF3 募集到共享的结合位点。在开放增强子和启动子上的协同结合导致成纤维细胞基因沉默和 cDC1 程序的激活。这些发现为人类 cDC1 特化和重编程提供了机制见解,并代表了生成患者定制的 cDC1 的平台,这是癌症免疫治疗中疫苗策略中长期寻求的 DC 亚群。

相似文献

1
Single-cell transcriptional profiling informs efficient reprogramming of human somatic cells to cross-presenting dendritic cells.单细胞转录组谱分析指导高效重编程人源体细胞为交叉呈递树突状细胞。
Sci Immunol. 2022 Mar 4;7(69):eabg5539. doi: 10.1126/sciimmunol.abg5539.
2
Direct Reprogramming of Mouse Embryonic Fibroblasts to Conventional Type 1 Dendritic Cells by Enforced Expression of Transcription Factors.通过转录因子的强制表达将小鼠胚胎成纤维细胞直接重编程为传统1型树突状细胞
Bio Protoc. 2020 May 20;10(10):e3619. doi: 10.21769/BioProtoc.3619.
3
-Dependent Genes Control Tumor Rejection Induced by Dendritic Cells Independently of Cross-Presentation.依赖基因独立于交叉呈递控制树突状细胞诱导的肿瘤排斥
Cancer Immunol Res. 2019 Jan;7(1):29-39. doi: 10.1158/2326-6066.CIR-18-0138. Epub 2018 Nov 27.
4
Effective cancer immunotherapy by natural mouse conventional type-1 dendritic cells bearing dead tumor antigen.携带死肿瘤抗原的天然小鼠常规型 1 树突状细胞的有效癌症免疫疗法。
J Immunother Cancer. 2019 Apr 8;7(1):100. doi: 10.1186/s40425-019-0565-5.
5
IRF8 and BATF3 interaction enhances the cDC1 specific Pfkfb3 gene expression.IRF8 和 BATF3 相互作用增强了 cDC1 特异性 Pfkfb3 基因的表达。
Cell Immunol. 2022 Jan;371:104468. doi: 10.1016/j.cellimm.2021.104468. Epub 2021 Dec 10.
6
Restoring tumor immunogenicity with dendritic cell reprogramming.利用树突状细胞重编程恢复肿瘤免疫原性。
Sci Immunol. 2023 Jul 14;8(85):eadd4817. doi: 10.1126/sciimmunol.add4817. Epub 2023 Jul 7.
7
IRF8 deficiency induces the transcriptional, functional, and epigenetic reprogramming of cDC1 into the cDC2 lineage.IRF8 缺陷诱导 cDC1 向 cDC2 谱系的转录、功能和表观遗传重编程。
Immunity. 2022 Aug 9;55(8):1431-1447.e11. doi: 10.1016/j.immuni.2022.06.006. Epub 2022 Jul 12.
8
Cryptic activation of an Irf8 enhancer governs cDC1 fate specification.IRF8 增强子的隐匿激活控制 cDC1 命运特化。
Nat Immunol. 2019 Sep;20(9):1161-1173. doi: 10.1038/s41590-019-0450-x. Epub 2019 Aug 12.
9
Vaccine efficacy against primary and metastatic cancer with in vitro-generated CD103 conventional dendritic cells.体外生成的 CD103 常规树突状细胞对原发性和转移性癌症的疫苗疗效。
J Immunother Cancer. 2020 Apr;8(1). doi: 10.1136/jitc-2019-000474.
10
IRF8-Dependent Type I Conventional Dendritic Cells (cDC1s) Control Post-Ischemic Inflammation and Mildly Protect Against Post-Ischemic Acute Kidney Injury and Disease.IRF8 依赖性 I 型经典树突状细胞(cDC1)控制缺血后炎症,并轻度预防缺血性急性肾损伤和疾病。
Front Immunol. 2021 Jun 21;12:685559. doi: 10.3389/fimmu.2021.685559. eCollection 2021.

引用本文的文献

1
Conversion of natural cytokine receptors into orthogonal synthetic biosensors.将天然细胞因子受体转化为正交合成生物传感器。
Nat Chem Biol. 2025 Aug 22. doi: 10.1038/s41589-025-01986-1.
2
PU.1 regulation of type 1 dendritic cell function via NF-κB pathway in inhibition of non-small cell lung cancer progression.PU.1通过NF-κB途径调节1型树突状细胞功能以抑制非小细胞肺癌进展
J Pharm Anal. 2025 Jul;15(7):101154. doi: 10.1016/j.jpha.2024.101154. Epub 2024 Nov 22.
3
Comparing gene-gene co-expression network approaches for the analysis of cell differentiation and specification on scRNAseq data.

本文引用的文献

1
Cell Fate Reprogramming in the Era of Cancer Immunotherapy.癌症免疫治疗时代的细胞命运重编程。
Front Immunol. 2021 Jul 21;12:714822. doi: 10.3389/fimmu.2021.714822. eCollection 2021.
2
Direct cell reprogramming: approaches, mechanisms and progress.直接细胞重编程:方法、机制与进展。
Nat Rev Mol Cell Biol. 2021 Jun;22(6):410-424. doi: 10.1038/s41580-021-00335-z. Epub 2021 Feb 22.
3
Dendritic Cells Revisited.树突状细胞再探。
比较基因-基因共表达网络方法以分析单细胞RNA测序数据中的细胞分化和特化
Comput Struct Biotechnol J. 2025 Jun 6;27:2747-2756. doi: 10.1016/j.csbj.2025.05.040. eCollection 2025.
4
Dendritic cell-derived exosomes as anti-cancer cell-free agents: new insights into enhancing immunogenic effects.树突状细胞衍生的外泌体作为无细胞抗癌剂:增强免疫原性作用的新见解
Front Immunol. 2025 May 28;16:1586892. doi: 10.3389/fimmu.2025.1586892. eCollection 2025.
5
Peptide-MHC I regulatory mechanisms and intervention strategies in anti-tumor T cell immunity.肽-MHC I在抗肿瘤T细胞免疫中的调节机制及干预策略
Acta Pharmacol Sin. 2025 May 16. doi: 10.1038/s41401-025-01574-y.
6
Exploring the pathogenesis and clinical implications of asthma, chronic obstructive pulmonary disease (COPD), and asthma-COPD overlap (ACO): a narrative review.探索哮喘、慢性阻塞性肺疾病(COPD)及哮喘-慢性阻塞性肺疾病重叠综合征(ACO)的发病机制及临床意义:一项叙述性综述
Front Med (Lausanne). 2025 Apr 17;12:1514846. doi: 10.3389/fmed.2025.1514846. eCollection 2025.
7
Immunological Regulation of Fibrosis During Heart Failure: It Takes Two to Tango.心力衰竭期间纤维化的免疫调节:两人才能跳探戈。
Biomolecules. 2025 Jan 3;15(1):58. doi: 10.3390/biom15010058.
8
In vivo dendritic cell reprogramming for cancer immunotherapy.体内树突状细胞重编程用于癌症免疫治疗。
Science. 2024 Oct 18;386(6719):eadn9083. doi: 10.1126/science.adn9083.
9
Associating transcription factors to single-cell trajectories with DREAMIT.使用 DREAMIT 将转录因子与单细胞轨迹关联。
Genome Biol. 2024 Aug 14;25(1):220. doi: 10.1186/s13059-024-03368-7.
10
Machine Learning-Directed Conversion of Glioblastoma Cells to Dendritic Cell-Like Antigen-Presenting Cells as Cancer Immunotherapy.机器学习引导的胶质母细胞瘤细胞向树突状细胞样抗原呈递细胞的转化作为癌症免疫疗法
Cancer Immunol Res. 2024 Oct 1;12(10):1340-1360. doi: 10.1158/2326-6066.CIR-23-0721.
Annu Rev Immunol. 2021 Apr 26;39:131-166. doi: 10.1146/annurev-immunol-061020-053707. Epub 2021 Jan 22.
4
High Amount of Transcription Factor IRF8 Engages AP1-IRF Composite Elements in Enhancers to Direct Type 1 Conventional Dendritic Cell Identity.高量转录因子 IRF8 结合 AP1-IRF 复合元件于增强子上,以指导 1 型常规树突状细胞的特性。
Immunity. 2020 Oct 13;53(4):759-774.e9. doi: 10.1016/j.immuni.2020.07.018. Epub 2020 Aug 13.
5
Generalizing RNA velocity to transient cell states through dynamical modeling.通过动态建模将 RNA 速度推广到瞬时细胞状态。
Nat Biotechnol. 2020 Dec;38(12):1408-1414. doi: 10.1038/s41587-020-0591-3. Epub 2020 Aug 3.
6
Differential IRF8 Transcription Factor Requirement Defines Two Pathways of Dendritic Cell Development in Humans.差异的 IRF8 转录因子需求定义了人类树突状细胞发育的两条途径。
Immunity. 2020 Aug 18;53(2):353-370.e8. doi: 10.1016/j.immuni.2020.07.003. Epub 2020 Jul 30.
7
IFN-III is selectively produced by cDC1 and predicts good clinical outcome in breast cancer.IFN-III 由 cDC1 选择性产生,并可预测乳腺癌的良好临床结局。
Sci Immunol. 2020 Apr 17;5(46). doi: 10.1126/sciimmunol.aav3942.
8
Mechanisms governing the pioneering and redistribution capabilities of the non-classical pioneer PU.1.调控非经典先驱转录因子 PU.1 启动和重分布能力的机制。
Nat Commun. 2020 Jan 21;11(1):402. doi: 10.1038/s41467-019-13960-2.
9
Understanding and Modulating Immunity With Cell Reprogramming.利用细胞重编程理解和调节免疫。
Front Immunol. 2019 Dec 11;10:2809. doi: 10.3389/fimmu.2019.02809. eCollection 2019.
10
scPred: accurate supervised method for cell-type classification from single-cell RNA-seq data.scPred:一种准确的有监督方法,用于对单细胞 RNA-seq 数据进行细胞类型分类。
Genome Biol. 2019 Dec 12;20(1):264. doi: 10.1186/s13059-019-1862-5.